Page last updated: 2024-12-08
chromocarb diethylamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
chromocarb diethylamine: treatment for certain forms of hemorrhagic anal inflammations [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 159960 |
SCHEMBL ID | 3909750 |
MeSH ID | M0098532 |
Synonyms (22)
Synonym |
---|
chromocarb diethylamine |
angiophtal |
4-oxo-4h-1-benzopyran-2-carboxylic acid, compound with diethylamine (1:1) |
diethylamine chromone-carboxylate-2 |
fludarene |
einecs 245-939-9 |
chromocarbe diethylamine |
campel (tn) |
chromocarb diethylazan |
23915-80-2 |
D07696 |
unii-r0o8tf63dh |
r0o8tf63dh , |
diethylamine, 4-oxo-4h-1-benzopyran-2-carboxylate |
chromocarb diethylamine [who-dd] |
chromocarb diethylamine [mart.] |
chromocarb diethylamine [mi] |
n,n-diethylammonium chromone-2-carboxylate |
ethanamine, n-ethyl-, 4-oxo-4h-1-benzopyran-2-carboxylate |
SCHEMBL3909750 |
DTXSID10178628 |
Q27287618 |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"In order to evaluate the influence of food and time of administration on the absorption of diethylamine chromocarbe, a bioavailability study was performed in 8 volunteers by using a new method of plasmatic drug evaluation." | ( The effect of food and time of administration on the absorption of diethylamine chromocarbe. Aiache, JM; Aiache, S; Faurie, M; Kaftelip, JP; Sibaud, Y, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.30) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 4 (33.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (66.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |